As of 10:46am ET
| +0.58 / +1.32%|
The 4 analysts offering 12-month price forecasts for Anika Therapeutics Inc have a median target of 49.50, with a high estimate of 51.00 and a low estimate of 46.00. The median estimate represents a +12.39% increase from the last price of 44.05.
The current consensus among 4 polled investment analysts is to Buy stock in Anika Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.